IOBENGUANE I-123

IOBENGUANE I-123 was reported 114 times

IOBENGUANE I-123 is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN ANTI-MOUSE ANTIBODY POSITIVE 2 0.1176
1 MYXOMA 1 0.0714
2 URINE IODINE INCREASED 1 0.0417
3 RADIOISOTOPE SCAN ABNORMAL 20 0.0283
4 NEUROBLASTOMA RECURRENT 5 0.0246
5 FALSE POSITIVE INVESTIGATION RESULT 3 0.0030
6 NEUROBLASTOMA 1 0.0026
7 URETERIC STENOSIS 2 0.0025
8 NUTRITIONAL CONDITION ABNORMAL 1 0.0014
9 FALSE NEGATIVE INVESTIGATION RESULT 1 0.0014
10 HEMIANOPIA HOMONYMOUS 1 0.0014
11 ANTIBODY TEST POSITIVE 2 0.0012
12 PREMATURE MENOPAUSE 1 0.0011
13 HYPOPERFUSION 1 0.0010
14 ELECTROCARDIOGRAM T WAVE ABNORMAL 1 0.0006
15 OPTIC ATROPHY 1 0.0006
16 MUCOSAL INFLAMMATION 14 0.0005
17 MOTION SICKNESS 1 0.0005
18 CANCER PAIN 1 0.0004
19 HYDRONEPHROSIS 2 0.0003
20 THERAPY PARTIAL RESPONDER 4 0.0003
21 EPIGASTRIC DISCOMFORT 1 0.0003
22 SUSPECTED COUNTERFEIT PRODUCT 1 0.0003
23 METASTATIC NEOPLASM 1 0.0002
24 NO ADVERSE EVENT 41 0.0002
25 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 2 0.0002
26 MYELODYSPLASTIC SYNDROME 3 0.0002
27 HYPERVOLAEMIA 1 0.0002
28 DERMATITIS EXFOLIATIVE 1 0.0002
29 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
30 PULMONARY ALVEOLAR HAEMORRHAGE 1 0.0002
31 NEUTROPENIA 22 0.0002
32 WRONG DRUG ADMINISTERED 1 0.0001
33 INABILITY TO AFFORD MEDICATION 1 0.0001
34 INJECTION SITE EXTRAVASATION 1 0.0001
35 FEBRILE NEUTROPENIA 5 0.0001
36 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
37 THERAPY NON-RESPONDER 3 0.0001
38 THYROID DISORDER 1 0.0001
39 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
40 BONE MARROW FAILURE 1 0.0000
41 LIVER FUNCTION TEST INCREASED 1 0.0000
42 ORAL PAIN 1 0.0000
43 RASH ERYTHEMATOUS 2 0.0000
44 INJECTION SITE URTICARIA 1 0.0000
45 PALLOR 1 0.0000
46 RESPIRATORY DISTRESS 1 0.0000
47 SWOLLEN TONGUE 1 0.0000
48 HYPOTHYROIDISM 1 0.0000
49 NEOPLASM PROGRESSION 1 0.0000
50 BURNING SENSATION 2 0.0000
51 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
52 CRYING 1 0.0000
53 THROAT IRRITATION 1 0.0000
54 SKIN DISCOLOURATION 1 0.0000
55 HYPOKALAEMIA 1 0.0000
56 PRODUCT USE ISSUE 4 0.0000
57 SYNCOPE 2 0.0000
58 FLUID RETENTION 1 0.0000
59 PRODUCT SUBSTITUTION ISSUE 1 0.0000
60 BONE PAIN 1 0.0000
61 STOMATITIS 1 0.0000
62 FEELING HOT 1 0.0000
63 DRUG INEFFECTIVE 21 0.0000
64 BLOOD PRESSURE DECREASED 1 0.0000
65 PRODUCT QUALITY ISSUE 2 0.0000
66 DYSGEUSIA 1 0.0000
67 EPISTAXIS 1 0.0000
68 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
69 URTICARIA 2 0.0000
70 RENAL IMPAIRMENT 1 0.0000
71 PYREXIA 4 0.0000
72 TACHYCARDIA 1 0.0000
73 FLUSHING 1 0.0000
74 CHEST DISCOMFORT 1 0.0000
75 PLATELET COUNT DECREASED 1 0.0000
76 VOMITING 4 0.0000
77 DISEASE PROGRESSION 1 0.0000
78 HYPERHIDROSIS 1 0.0000
79 DEHYDRATION 1 0.0000
80 FATIGUE 5 0.0000
81 PARAESTHESIA 1 0.0000
82 TREMOR 1 0.0000
83 MYALGIA 1 0.0000
84 ERYTHEMA 1 0.0000
85 ABDOMINAL PAIN UPPER 1 0.0000
86 HYPERTENSION 1 0.0000
87 DECREASED APPETITE 1 0.0000
88 DIZZINESS 2 0.0000
89 WEIGHT DECREASED 1 0.0000
90 COUGH 1 0.0000
91 DYSPNOEA 2 0.0000
92 HEADACHE 2 0.0000
93 PNEUMONIA 1 0.0000
94 NAUSEA 2 0.0000
95 ARTHRALGIA 1 0.0000
96 OFF LABEL USE 2 0.0000
97 MALAISE 1 0.0000